These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35440040)

  • 1. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
    Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
    Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chordoid Meningioma: Differentiating a Rare World Health Organization Grade II Tumor from Other Meningioma Histologic Subtypes Using MRI.
    Pond JB; Morgan TG; Hatanpaa KJ; Yetkin ZF; Mickey BE; Mendelsohn DB
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1253-8. PubMed ID: 25882286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
    Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
    Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
    Kirches E; Sahm F; Korshunov A; Bluecher C; Waldt N; Kropf S; Schrimpf D; Sievers P; Stichel D; Schüller U; Schittenhelm J; Riemenschneider MJ; Karajannis MA; Perry A; Pietsch T; Boekhoff S; Capper D; Beck K; Paramasivam N; Schlesner M; Brastianos PK; Müller HL; Pfister SM; Mawrin C
    Acta Neuropathol; 2021 Nov; 142(5):873-886. PubMed ID: 34495383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
    Bollag RJ; Vender JR; Sharma S
    Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF chromatin remodeling complex alterations in meningioma.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
    Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
    J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review.
    Okano A; Miyawaki S; Teranishi Y; Ohara K; Hongo H; Sakai Y; Ishigami D; Nakatomi H; Saito N
    Neurol Med Chir (Tokyo); 2022 Aug; 62(8):347-360. PubMed ID: 35871574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
    Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
    Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories.
    Ng HK; Li KK; Chung NY; Chan JY; Poon MF; Wong QH; Kwan JS; Poon WS; Chen H; Chan DT; Shi ZF; Mao Y
    Brain Pathol; 2023 May; 33(3):e13120. PubMed ID: 36167400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of
    Malgulwar PB; Kakkar A; Sharma MC; Ghosh R; Pathak P; Sarkar C; Suri V; Singh M; Kale SS; Faruq M
    Neurol India; 2019; 67(6):1492-1497. PubMed ID: 31857543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
    Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression.
    Cain SA; Pope B; Mangiola S; Mantamadiotis T; Drummond KJ
    BMC Cancer; 2023 Mar; 23(1):216. PubMed ID: 36882706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic alterations in meningiomas.
    Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
    Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.